| Pituitary adenylate cyclase-activating polypeptide and its receptors: 20 years after the discovery D Vaudry, A Falluel-Morel, S Bourgault, M Basille, D Burel, O Wurtz, ... Pharmacological reviews 61 (3), 283-357, 2009 | 1128 | 2009 |
| Nanoparticle-based vaccines against respiratory viruses S Al-Halifa, L Gauthier, D Arpin, S Bourgault, D Archambault Frontiers in immunology 10, 435389, 2019 | 257 | 2019 |
| Novel stable PACAP analogs with potent activity towards the PAC1 receptor S Bourgault, D Vaudry, B Botia, A Couvineau, M Laburthe, H Vaudry, ... Peptides 29 (6), 919-932, 2008 | 153 | 2008 |
| The neurotrophic effects of PACAP in PC12 cells: control by multiple transduction pathways A Ravni, S Bourgault, A Lebon, P Chan, L Galas, A Fournier, H Vaudry, ... Journal of neurochemistry 98 (2), 321-329, 2006 | 139 | 2006 |
| Sulfated glycosaminoglycans accelerate transthyretin amyloidogenesis by quaternary structural conversion S Bourgault, JP Solomon, N Reixach, JW Kelly Biochemistry 50 (6), 1001-1015, 2011 | 120 | 2011 |
| Mechanisms of transthyretin cardiomyocyte toxicity inhibition by resveratrol analogs S Bourgault, S Choi, JN Buxbaum, JW Kelly, JL Price, N Reixach Biochemical and biophysical research communications 410 (4), 707-713, 2011 | 109 | 2011 |
| Pituitary adenylate cyclase-activating polypeptide: focus on structure-activity relationships of a neuroprotective peptide S Bourgault, D Vaudry, A Dejda, ND Doan, H Vaudry, A Fournier Current medicinal chemistry 16 (33), 4462-4480, 2009 | 108 | 2009 |
| Inhibitory effect of PACAP on caspase activity in neuronal apoptosis: a better understanding towards therapeutic applications in neurodegenerative diseases A Dejda, V Jolivel, S Bourgault, T Seaborn, A Fournier, H Vaudry, ... Journal of molecular neuroscience 36 (1), 26-37, 2008 | 104 | 2008 |
| Molecular and conformational determinants of pituitary adenylate cyclase-activating polypeptide (PACAP) for activation of the PAC1 receptor S Bourgault, D Vaudry, I Ségalas-Milazzo, L Guilhaudis, A Couvineau, ... Journal of medicinal chemistry 52 (10), 3308-3316, 2009 | 95 | 2009 |
| Functional and binding characterizations of urotensin II-related peptides in human and rat urotensin II-receptor assay A Brkovic, A Hattenberger, E Kostenis, T Klabunde, S Flohr, M Kurz, ... Journal of Pharmacology and Experimental Therapeutics 306 (3), 1200-1209, 2003 | 85 | 2003 |
| Endogenous retrovirus-encoded Syncytin-2 contributes to exosome-mediated immunosuppression of T cells AG Lokossou, C Toudic, PT Nguyen, X Elisseeff, A Vargas, É Rassart, ... Biology of reproduction 102 (1), 185-198, 2020 | 81 | 2020 |
| PACAP and a novel stable analog protect rat brain from ischemia: Insight into the mechanisms of action A Dejda, T Seaborn, S Bourgault, O Touzani, A Fournier, H Vaudry, ... Peptides 32 (6), 1207-1216, 2011 | 77 | 2011 |
| Delineating the role of helical intermediates in natively unfolded polypeptide amyloid assembly and cytotoxicity CA De Carufel, N Quittot, PT Nguyen, S Bourgault Angewandte Chemie 127 (48), 14591-14595, 2015 | 70 | 2015 |
| Thioflavin T fluorescence to analyse amyloid formation kinetics: Measurement frequency as a factor explaining irreproducibility M Sebastiao, N Quittot, S Bourgault Analytical biochemistry 532, 83-86, 2017 | 59 | 2017 |
| New insights into the roles of sulfated glycosaminoglycans in islet amyloid polypeptide amyloidogenesis and cytotoxicity CA De Carufel, PT Nguyen, S Sahnouni, S Bourgault Peptide Science 100 (6), 645-655, 2013 | 58 | 2013 |
| Strategies to convert PACAP from a hypophysiotropic neurohormone into a neuroprotective drug S Bourgault, D Chatenet, O Wurtz, N D Doan, J Leprince, H Vaudry, ... Current pharmaceutical design 17 (10), 1002-1024, 2011 | 58 | 2011 |
| Heparin binds 8 kDa gelsolin cross-β-sheet oligomers and accelerates amyloidogenesis by hastening fibril extension JP Solomon, S Bourgault, ET Powers, JW Kelly Biochemistry 50 (13), 2486-2498, 2011 | 57 | 2011 |
| Design and in vitro characterization of PAC1/VPAC1-selective agonists with potent neuroprotective effects ND Doan, S Bourgault, A Dejda, M Létourneau, M Detheux, D Vaudry, ... Biochemical pharmacology 81 (4), 552-561, 2011 | 53 | 2011 |
| Compartmentalized processing of catechols during mussel byssus fabrication determines the destiny of DOPA T Priemel, R Palia, M Babych, CJ Thibodeaux, S Bourgault, MJ Harrington Proceedings of the National Academy of Sciences 117 (14), 7613-7621, 2020 | 52 | 2020 |
| Truncated netrin-1 contributes to pathological vascular permeability in diabetic retinopathy K Miloudi, F Binet, A Wilson, A Cerani, M Oubaha, C Menard, S Henriques, ... The Journal of clinical investigation 126 (8), 3006-3022, 2016 | 49 | 2016 |
